Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has received an average recommendation of “Moderate Buy” from the nine analysts that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month price objective […]
Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the nine analysts that are presently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average twelve-month target price among […]
Terns Pharmaceuticals, Inc (NASDAQ:TERN) Receives $16 11 Average Price Target from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Terns Pharmaceuticals (NASDAQ:TERN – Free Report) had its price objective lifted by JPMorgan Chase & Co. from $10.00 to $11.00 in a report published on Wednesday morning, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock. Other research analysts have also recently issued research reports about the stock. Roth Mkm […]
Terns Pharmaceuticals (NASDAQ:TERN – Free Report) had its price target upped by Mizuho from $16.00 to $17.00 in a research note issued to investors on Wednesday, FlyOnTheWall reports. Several other research firms have also recently issued reports on TERN. Roth Mkm reissued a buy rating and set a $23.00 target price on shares of Terns […]